Person

Jan De Witte

Director, ResMed

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$1.4M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 25, 2025RMDSale2,055$255.00$524K
Nov 11, 2025RMDSale487$250.25$122K
May 20, 2025RMDSale2,000$243.47$487K
Nov 12, 2024RMDSale796$248.81$198K
May 15, 2024RMDSale360$218.29$79K

SEC reporting-owner ID (CIK) 1776929 · all filings on EDGAR

Jan De Witte (RMD) | USBoard